Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1 H-tetrazols as novel microtubule destabilizers

J Enzyme Inhib Med Chem. 2021 Dec;36(1):549-560. doi: 10.1080/14756366.2020.1759582.

Abstract

A series of 1-aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as microtubule destabilizers were designed, synthesised and evaluated for anticancer activity. Based on bioisosterism, we introduced the tetrazole moiety containing the hydrogen-bond acceptors as B-ring of XRP44X analogues. The key intermediates ethyl 1-aryl-1H-tetrazole-5-carboxylates 10 can be simply and efficiently prepared via a microwave-assisted continuous operation process. Among the compounds synthesised, compound 6-31 showed noteworthy potency against SGC-7901, A549 and HeLa cell lines. In mechanism studies, compound 6-31 inhibited tubulin polymerisation and disorganised microtubule in SGC-7901 cells by binding to tubulin. Moreover, compound 6-31 arrested SGC-7901cells in G2/M phase. This study provided a new perspective for development of antitumor agents that target tubulin.

Keywords: Tetrazole; antiproliferative activity; microtubule destabilizer; microwave; molecular docking.

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Dose-Response Relationship, Drug
  • Drug Design*
  • Drug Screening Assays, Antitumor
  • Humans
  • Microtubules / drug effects*
  • Microtubules / metabolism
  • Microwaves
  • Models, Molecular
  • Molecular Structure
  • Polymerization / drug effects
  • Structure-Activity Relationship
  • Tetrazoles / chemical synthesis
  • Tetrazoles / chemistry
  • Tetrazoles / pharmacology*
  • Tubulin / metabolism
  • Tubulin Modulators / chemical synthesis
  • Tubulin Modulators / chemistry
  • Tubulin Modulators / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Tetrazoles
  • Tubulin
  • Tubulin Modulators

Grants and funding

We gratefully acknowledge the National Natural Science Foundation of China [81673293 and 81602969], Project funded by China Postdoctoral Science Foundation [2018M641715], Liaoning Revitalisation Talents Programme [XLYC1802072] and Plan for Development of Young Scholars of Shenyang pharmaceutical university [ZQN2018002] for the generous financial support. This work was also supported by the Programme for Innovative Research Team of the Ministry of Education.